A Meningococcal Outer Membrane Vesicle Vaccine Incorporating Genetically Attenuated Endotoxin Dissociates Inflammation From Immunogenicity
Background. Group B Neisseria meningitidis, an endotoxin-producing gram-negative bacterium, causes the highest incidence of group B meningococcus (MenB) disease in the first year of life. The Bexsero vaccine is indicated in Europe from 8 weeks of age. Endotoxin components of outer membrane vesicles...
Main Authors: | David J. Dowling, Holly Sanders, Wing Ki Cheng, Sweta Joshi, Spencer Brightman, Ilana Bergelson, Carlo Pietrasanta, Simon Daniel Van Haren, Sandra van Amsterdam, Jeffrey Fernandez, Germie P.J.M. van den Dobbelsteen, Ofer Levy |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00562/full |
Similar Items
-
Acute myelopathy with sudden paraplegia as the sole manifestation of meningococcal meningitis
by: Wanis H. Ibrahim, et al.
Published: (2010-02-01) -
Meningococcal Carriage among Household Contacts of Patients with Invasive Meningococcal Disease in Kathmandu, Nepal: A Longitudinal Study
by: Supriya Sharma, et al.
Published: (2021-06-01) -
Invasive Meningococcal Disease, Utah, 1995–2005
by: Rachelle B. Boulton, et al.
Published: (2007-08-01) -
Ex-vivo assessment of meningococcal resistance to natural immunity: serum bactericidal assays versus whole- blood assay
by: Nosratollah Saeed Adeli, et al.
Published: (2009-01-01) -
Lactobacillus paracasei feeding improves the control of secondary experimental meningococcal infection in flu-infected mice
by: Nouria Belkacem, et al.
Published: (2018-04-01)